nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Gallamine Triethiodide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Gallamine Triethiodide—Pain—Melphalan—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Epirubicin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Gallamine Triethiodide—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gallamine Triethiodide—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Gallamine Triethiodide—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Gallamine Triethiodide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gallamine Triethiodide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gallamine Triethiodide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Epirubicin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Gallamine Triethiodide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Gallamine Triethiodide—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Gallamine Triethiodide—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Gallamine Triethiodide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Gallamine Triethiodide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Gallamine Triethiodide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Gallamine Triethiodide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Gallamine Triethiodide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Gallamine Triethiodide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gallamine Triethiodide—Malaise—Etoposide—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gallamine Triethiodide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Rash—Topotecan—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Cough—Etoposide—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Headache—Topotecan—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Pain—Vincristine—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Rash—Melphalan—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Gallamine Triethiodide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Gallamine Triethiodide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Gallamine Triethiodide—Pain—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Gallamine Triethiodide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Gallamine Triethiodide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Gallamine Triethiodide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Gallamine Triethiodide—Pain—Etoposide—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Gallamine Triethiodide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Gallamine Triethiodide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Gallamine Triethiodide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Gallamine Triethiodide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Gallamine Triethiodide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Gallamine Triethiodide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Gallamine Triethiodide—Rash—Vincristine—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Gallamine Triethiodide—Headache—Vincristine—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Gallamine Triethiodide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gallamine Triethiodide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gallamine Triethiodide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Gallamine Triethiodide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000997	0.000997	CcSEcCtD
Gallamine Triethiodide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000988	0.000988	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000987	0.000987	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000982	0.000982	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00098	0.00098	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000973	0.000973	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000966	0.000966	CcSEcCtD
Gallamine Triethiodide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
Gallamine Triethiodide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000913	0.000913	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000912	0.000912	CcSEcCtD
Gallamine Triethiodide—Rash—Etoposide—peripheral nervous system neoplasm	0.000905	0.000905	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000905	0.000905	CcSEcCtD
Gallamine Triethiodide—Headache—Etoposide—peripheral nervous system neoplasm	0.0009	0.0009	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000894	0.000894	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000889	0.000889	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000883	0.000883	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000861	0.000861	CcSEcCtD
Gallamine Triethiodide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000853	0.000853	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000843	0.000843	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00084	0.00084	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00084	0.00084	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000834	0.000834	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000823	0.000823	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000817	0.000817	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000812	0.000812	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000782	0.000782	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000777	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000777	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000772	0.000772	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000751	0.000751	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000733	0.000733	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000729	0.000729	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000727	0.000727	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000695	0.000695	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000694	0.000694	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000688	0.000688	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000669	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000663	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000642	0.000642	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000637	0.000637	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000636	0.000636	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000636	0.000636	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.000614	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000593	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000592	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Gallamine Triethiodide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Gallamine Triethiodide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000569	0.000569	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000551	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000534	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Gallamine Triethiodide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00051	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Gallamine Triethiodide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
